Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol. 1977

C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug

Related Publications

C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
February 1977, British journal of clinical pharmacology,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
May 1980, British heart journal,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
March 1986, British journal of anaesthesia,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
January 1986, European journal of clinical pharmacology,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
January 1982, British journal of clinical pharmacology,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
January 1983, Journal de pharmacologie,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
January 1983, Artery,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
January 1989, European journal of clinical pharmacology,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
December 1976, Clinical science and molecular medicine. Supplement,
C L van Herwaarden, and J F Fennis, and R A Binkhorst, and A van't Laar
January 1982, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!